The CD8+ dendritic cell subset
- PMID: 20193009
- DOI: 10.1111/j.0105-2896.2009.00870.x
The CD8+ dendritic cell subset
Abstract
Mouse lymphoid tissues contain a subset of dendritic cells (DCs) expressing CD8 alpha together with a pattern of other surface molecules that distinguishes them from other DCs. These molecules include particular Toll-like receptor and C-type lectin pattern recognition receptors. A similar DC subset, although lacking CD8 expression, exists in humans. The mouse CD8(+) DCs are non-migrating resident DCs derived from a precursor, distinct from monocytes, that continuously seeds the lymphoid organs from bone marrow. They differ in several key functions from their CD8(-) DC neighbors. They efficiently cross-present exogenous cell-bound and soluble antigens on major histocompatibility complex class I. On activation, they are major producers of interleukin-12 and stimulate inflammatory responses. In steady state, they have immune regulatory properties and help maintain tolerance to self-tissues. During infection with intracellular pathogens, they become major presenters of pathogen antigens, promoting CD8(+) T-cell responses to the invading pathogens. Targeting vaccine antigens to the CD8(+) DCs has proved an effective way to induce cytotoxic T lymphocytes and antibody responses.
Similar articles
-
Unique functions of splenic CD8alpha+ dendritic cells during infection with intracellular pathogens.Immunol Lett. 2007 Dec 15;114(2):66-72. doi: 10.1016/j.imlet.2007.09.007. Epub 2007 Oct 12. Immunol Lett. 2007. PMID: 17964665 Review.
-
Comparative genomics as a tool to reveal functional equivalences between human and mouse dendritic cell subsets.Immunol Rev. 2010 Mar;234(1):177-98. doi: 10.1111/j.0105-2896.2009.00868.x. Immunol Rev. 2010. PMID: 20193019 Review.
-
Novel subset of CD8{alpha}+ dendritic cells localized in the marginal zone is responsible for tolerance to cell-associated antigens.J Immunol. 2009 Apr 1;182(7):4127-36. doi: 10.4049/jimmunol.0803364. J Immunol. 2009. PMID: 19299710
-
Origin and development of dendritic cells.Immunol Rev. 2010 Mar;234(1):45-54. doi: 10.1111/j.0105-2896.2009.00879.x. Immunol Rev. 2010. PMID: 20193011 Review.
-
Development and functional specialization of CD103+ dendritic cells.Immunol Rev. 2010 Mar;234(1):268-81. doi: 10.1111/j.0105-2896.2009.00874.x. Immunol Rev. 2010. PMID: 20193025 Review.
Cited by
-
Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3+ dendritic cells at cross presentation.J Exp Med. 2013 May 6;210(5):1049-63. doi: 10.1084/jem.20121251. Epub 2013 Apr 8. J Exp Med. 2013. PMID: 23569326 Free PMC article.
-
Deciphering the transcriptional network of the dendritic cell lineage.Nat Immunol. 2012 Sep;13(9):888-99. doi: 10.1038/ni.2370. Epub 2012 Jul 15. Nat Immunol. 2012. PMID: 22797772 Free PMC article.
-
CD8 marks a subpopulation of lung-derived dendritic cells with differential responsiveness to viral infection and toll-like receptor stimulation.J Virol. 2012 Oct;86(19):10640-50. doi: 10.1128/JVI.01413-12. Epub 2012 Jul 18. J Virol. 2012. PMID: 22811544 Free PMC article.
-
IFNα and 5-Aza-2'-deoxycytidine combined with a dendritic-cell targeting DNA vaccine alter tumor immune cell infiltration in the B16F10 melanoma model.Front Immunol. 2023 Jan 19;13:1074644. doi: 10.3389/fimmu.2022.1074644. eCollection 2022. Front Immunol. 2023. PMID: 36741387 Free PMC article.
-
Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived β-glucans.Blood. 2011 Jun 23;117(25):6825-36. doi: 10.1182/blood-2011-02-339812. Epub 2011 Apr 29. Blood. 2011. PMID: 21531981 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
